Pulmonary tuberculosis relapse or atypical mycobacterium infection? Source: Annual Congress 2012 - Fungal, viral and other infections Year: 2012
Pulmonary tuberculosis with primary drug resistant mycobacterium tuberculosis -treatment outcomes Source: Eur Respir J 2004; 24: Suppl. 48, 657s Year: 2004
Inhaled therapies, azithromycin and Mycobacterium abscessus in cystic fibrosis patients Source: Eur Respir J 2013; 41: 1101-1106 Year: 2013
Clinical relevance of Mycobacterium malmoense isolation in the Netherlands Source: Eur Respir J 2009; 34: 926-931 Year: 2009
Localized pulmonary infection associated with Mycobacterium tilburgii in a HIV-infected patient Source: Eur Respir J 2005; 26: Suppl. 49, 191s Year: 2005
Disseminated nontuberculous infections with Mycobacterium genavense during sarcoidosis Source: Eur Respir Rev 2009; 18: 299-301 Year: 2009
Atypical manifestations of mycobacterium tuberculosis infection Source: Eur Respir J 2004; 24: Suppl. 48, 647s Year: 2004
Development of mycobacterium tuberculosis additional drug resistance during chemotherapy of disseminated pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 663s Year: 2007
Pulmonary tuberculosis among elderly and senile-aged patients depending on Mycobacterium strains Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
Pulmonary disease caused by M. malmoense in HIV negative patients: 5-yr follow-up of patients receiving standardised treatment Source: Eur Respir J 2003; 21: 478-482 Year: 2003
Treatment results of cases of severe pulmonary tuberculosis with using rifabutin Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001
Susceptibility of Mycobacterium tuberculosis strains to fluoquinolones, obtained from chronic patients with multidrug resistant pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 315s Year: 2001
Nontuberculous pulmonary mycobacteriosis caused by slowly growing nontuberculous mycobacteria as pulmonary comorbidity Source: Virtual Congress 2021 – Advances in diagnosis, treatment and clinical management of nontuberculous mycobacterial disease Year: 2021
A patient with cystic fibrosis and Mycobacterium abscessus infection Source: International Congress 2018 – CC1 Lung transplantation Year: 2018
Pulmonary aspergilloma complicated by a cavitary lesion caused by pulmonary Mycobacterium avium complex disease Source: Eur Respir J 2005; 26: Suppl. 49, 689s Year: 2005
Emerging untreatable non-tuberculous pulmonary disease due to Mycobacterium abscessus Source: Eur Respir J 2004; 24: Suppl. 48, 415s Year: 2004
Paradoxical reactions in non-HIV tuberculosis presenting as endobronchial obstruction Source: Eur Respir Rev 2009; 18: 295-299 Year: 2009
The spectrum of drug susceptibility of slow-growing nontuberculous mycobacteria (MAC, M. kansasii, M. xenopi) Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017
Bedaquiline as a potential agent in the treatment of Mycobacterium abscessus infections Source: Eur Respir J, 49 (5) 1700083; 10.1183/13993003.00083-2017 Year: 2017
Mycobacterium xenopi pulmonary disease in Croatia Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017